Product Information
LEVONOR-ETH ESTRAD 0.1-0.02 MG is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.1509 per EA under NDC 31722094432. Its NADAC has been published 120 times since May 8, 2024.
FDA first approved this application on Feb 13, 2023. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722094432
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA212298FDA Approved
2/13/2023
TE Code
AB1
On Market Since
2/13/2023
Price Statistics
The NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has been published 120 times since May 8, 2024, and over the history we have for it it has risen 3.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1509 per EA |
|---|---|
| All-time high | $0.1912 (Oct 16, 2024) |
| All-time low | $0.1212 (Jul 17, 2024) |
| 52-week high | $0.1741 |
| 52-week low | $0.1509 |
| Median price | $0.1561 |
| Average price | $0.1554 |
| Largest weekly change | +35.3% (Jun 19, 2024) |
| Weeks tracked | 120 |
| Tracking since | May 8, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Levonorgetsrel and Ethinyl Estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVONOR-ETH ESTRAD 0.1-0.02 MG?
The current National Average Drug Acquisition Cost (NADAC) for LEVONOR-ETH ESTRAD 0.1-0.02 MG, manufactured by Camber Pharmaceuticals Inc., is $0.1509 per EA (NDC 31722094432), effective Aug 19, 2026.
How has the price of LEVONOR-ETH ESTRAD 0.1-0.02 MG changed over time?
Over the history we have for it, the NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has risen 3.0%. It has been tracked across 120 weekly CMS publications since May 8, 2024.
What are the highest and lowest recorded NADAC prices for LEVONOR-ETH ESTRAD 0.1-0.02 MG?
Since May 8, 2024, the NADAC for LEVONOR-ETH ESTRAD 0.1-0.02 MG has ranged from a low of $0.1212 (Jul 17, 2024) to a high of $0.1912 (Oct 16, 2024), with a median of $0.1561 per EA.
Are there cheaper alternatives to LEVONOR-ETH ESTRAD 0.1-0.02 MG?
No other NADAC-published product currently shares the active ingredient and strength of LEVONOR-ETH ESTRAD 0.1-0.02 MG in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LEVONOR-ETH ESTRAD 0.1-0.02 MG?
LEVONOR-ETH ESTRAD 0.1-0.02 MG (NDC 31722094432) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.